Population Pharmacokinetics of Delavirdine and N -Delavirdine in HIV-Infected Individuals

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.44, Iss.1, 2005-01, pp. : 99-109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients

By Morse G.D.

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 323-328

Adis International

Access to resources Recommend Favorite

Effect of Food on the Steady-State Pharmacokinetics of Delavirdine in Patients with HIV Infection

By Morse G.D.

Clinical Drug Investigation, Vol. 23, Iss. 4, 2003-01 ,pp. : 255-261

Adis International

Access to resources Recommend Favorite

Delavirdine: Clinical Pharmacokinetics and Drug Interactions

By Tran J.Q.

Clinical Pharmacokinetics, Vol. 40, Iss. 3, 2001-01 ,pp. : 207-226

Adis International

Access to resources Recommend Favorite

Delavirdine: A Review of its Use in HIV Infection

By Scott L.J. Perry C.M.

Drugs, Vol. 60, Iss. 6, 2000-12 ,pp. : 1411-1444

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Efavirenz in an Unselected Cohort of HIV-1-Infected Individuals

By Kappelhoff Bregt S.

Clinical Pharmacokinetics, Vol. 44, Iss. 8, 2005-01 ,pp. : 849-861

Adis International

Access to resources Recommend Favorite